MedTrace Logo

Gluten Immunity and Islet Autoimmunity in Type-1 Diabetes

NCT01932476 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 7

Last updated 2017-04-17

No results posted yet for this study

Summary

The purpose of this study is to determine whether the immune response causing celiac disease is related to the autoimmune response causing type-1 diabetes.

Conditions

Interventions

DIETARY_SUPPLEMENT

Gluten Challenge

Three-day gluten containing dietary challenge.

DIETARY_SUPPLEMENT

Sham Challenge

Three-day sham (gluten free) dietary challenge

Sponsors & Collaborators

  • ImmusanT, Inc.

    collaborator INDUSTRY

  • Joslin Diabetes Center

    lead OTHER

Principal Investigators

  • Jason Gaglia, MD, MMSc · Joslin Diabetes Center

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-08-31
Primary Completion
2014-12-31
Completion
2014-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01932476 on ClinicalTrials.gov